Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
27,691,200
-
Total 13F shares
-
12,077,739
-
Share change
-
-2,292,216
-
Total reported value
-
$88,042,799
-
Price per share
-
$7.29
-
Number of holders
-
36
-
Value change
-
-$14,218,632
-
Number of buys
-
17
-
Number of sells
-
35
Institutional Holders of FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) as of Q2 2021
As of 30 Jun 2021 FENNEC PHARMACEUTICALS INC. - Common Shares (FENC) had 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 12,077,739 shares of stock of the company.
Largest 10 holders included Southpoint Capital Advisors LP, Sonic Fund II, L.P., Avoro Capital Advisors LLC, 683 Capital Management, LLC, Solas Capital Management, LLC, DG Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, HARBERT FUND ADVISORS, INC., Russell Investments Group, Ltd., and Ergoteles LLC.
This table shows 36 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.